BWI: Unichem Q3 Revenues Stood at Rs. 264.90 Crores and Profit After Tax and Before Exceptional items Stood at Rs. 32.14 Crores

Source : Unichem Laboratories Limited Monday, January 20, 2014 11:30AM IST (6:00AM GMT)   (BSE:506690) Unichem Q3 Revenues Stood at Rs. 264.90 Crores and Profit After Tax and Before Exceptional items Stood at Rs. 32.14 Crores   Goa, India The Board of Directors of Unichem Laboratories Ltd at their meeting held on January 18, 2014 approved the Third Quarter (Q3) Un-audited Results for FY 2013-14   The Company recorded a total income of Rs. 264.90 Crores for the quarter ended December 31, 2013 as against Rs. 232.57 Crores in the corresponding quarter of the previous year recording a growth of 14%. The Company recorded a Profit before interest & exceptional items of Rs. 41.28 Crores as against to Rs. 36.46 Crores in the corresponding quarter of the previous year recording a growth of 13%.   Profit after tax, excluding exceptional items, for the current quarter stood at Rs. 32.14 Crores as against Rs. 30.34 Crores recorded in the corresponding quarter of the previous year.   Profit after tax including exceptional items for the current quarter stood at Rs. 74.18 Crores as against Rs. 30.34 Crores recorded in the corresponding quarter of the previous year. Exceptional Items represents profits on sale of Company's manufacturing unit at SEZ, Indore and amortisation of Intangible assets due to change in their estimated useful life.   The Board declared an interim dividend of Rs.4 Per share (200%) on face value Rs. 2/- per share each. (Previous year final Dividend Rs. 4.50/- (225%) per share on Face Value share  of Rs. 2/- each).   About Unichem Laboratories Limited   Unichem Laboratories Limited is an International, integrated, speciality pharmaceutical Company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the Company is a leaded in niche areas of cardiology, neurology and other orthopadics and anti-infectives. The Company has strong skills in product development, process chemistry and manufacturing of complex API as well as dosage forms.   More information about the Company can be found at www.unichemlabs.com   Media Contact Details M Gundu Rao, Unichem Laboratories Limited, ,+91-9820228944 ,+91-22-66888380 , gundurao@unichemlabs.com Rakesh Parikh, Unichem Laboratories Limited, ,+91-9892925555 ,+91-22-66888414 , rparikh@unichemlabs.com Monish Shah, Unichem Laboratories Limited, ,+91-9819865421 ,+91-22-66888509 , monish.shah@unichemlabs.com   KEYWORDS: Business/ Finance:Accounting & management, Business Services, Healthcare & biotechnology, Heavy industries, Major diversified industrial groups, Manufacturing Companies, Medical Devices, Pharmaceutical, Stock Exchanges   If you wish to change your Business Wire India selection please visit on Business Wire India and use your personal username and password to login.   Submit your press release at http://www.businesswireindia.com

Note : This is system generated mail. Please do not reply to it.